Lopressor injection/contraindications: Difference between revisions

Jump to navigation Jump to search
mNo edit summary
No edit summary
 
(One intermediate revision by one other user not shown)
Line 1: Line 1:
__NOEDITSECTION____NOTOC__
__NOEDITSECTION____NOTOC__
{{ {{BASEPAGENAME}} }}
{{ {{BASEPAGENAME}} }}
{{CMG}}


* [[Hypersensitivity]] to [[Lopressor]] and related derivatives, or to any of the excipients
* [[Hypersensitivity]] to [[Lopressor]] and related derivatives, or to any of the excipients
* [[Hypersensitivity]] to other [[beta blocker]]s (cross sensitivity between beta blockers can occur)
* [[Hypersensitivity]] to other [[beta blocker]]s (cross sensitivity between [[beta blocker]]s can occur)
* [[Bradycardia]] with [[heart rate]] <45 beats/min
* [[Bradycardia]] with [[heart rate]] <45 beats/min
* [[Second degree AV block|Second-]] and [[Third degree AV block|third-degree heart block]]
* [[Second degree AV block|Second-]] and [[Third degree AV block|third-degree heart block]]

Latest revision as of 13:13, 21 March 2014

Lopressor injection/contraindications®
Black Box Warning
Adult Indications and Dosage
Pediatric Indications and Dosage
Contraindications
Warnings
Adverse Reactions
Drug Interactions
Use in Specific Populations
Administration and Monitoring
IV Compatibility
Overdosage
Pharmacology
Clinical Studies
How Supplied
Images
Patient information
Precautions with Alcohol
Look-Alike Drug Names
Drug Shortage Status
Price

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

References

  1. "LOPRESSOR (METOPROLOL TARTRATE) INJECTION, SOLUTION [NOVARTIS PHARMACEUTICALS CORPORATION]".